Exercise training inhibits macrophage-derived IL-17A-CXCL5-CXCR2 inflammatory axis to attenuate pulmonary fibrosis in mice exposed to silica

Sci Total Environ. 2023 Dec 1:902:166443. doi: 10.1016/j.scitotenv.2023.166443. Epub 2023 Aug 21.

Abstract

Exposure to crystalline silica leads to health effects beyond occupational silicosis. Exercise training's potential benefits on pulmonary diseases yield inconsistent outcomes. In this study, we utilized experimental silicotic mice subjected to exercise training and pharmacological interventions, including interleukin-17A (IL-17A) neutralizing antibody or clodronate liposome for macrophage depletion. Findings reveal exercise training's ability to mitigate silicosis progression in mice by suppressing scavenger receptor B (SRB)/NOD-like receptor thermal protein domain associated protein 3 (NLRP3) and Toll-like receptor 4 (TLR4) pathways. Macrophage-derived IL-17A emerges as primary source and trigger for silica-induced pulmonary inflammation and fibrosis. Exercise training effectively inhibits IL-17A-CXC motif chemokine ligand 5 (CXCL5)-Chemokine (C-X-C motif) Receptor 2 (CXCR2) axis in silicotic mice. Our study evidences exercise training's potential to reduce collagen deposition, preserve elastic fibers, slow pulmonary fibrosis advancement, and enhance pulmonary function post silica exposure by impeding macrophage-derived IL-17A-CXCL5-CXCR2 axis.

Keywords: CXC motif chemokine; Inflammatory response; Interleukin-17A; Silicosis.

MeSH terms

  • Animals
  • Chemokine CXCL5 / metabolism
  • Chemokines / metabolism
  • Exercise* / physiology
  • Inflammation
  • Interleukin-17 / metabolism
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Pulmonary Fibrosis* / chemically induced
  • Pulmonary Fibrosis* / metabolism
  • Pulmonary Fibrosis* / therapy
  • Receptors, Interleukin-8B / metabolism
  • Silicon Dioxide / toxicity
  • Silicosis* / metabolism
  • Silicosis* / therapy

Substances

  • Chemokines
  • Interleukin-17
  • Silicon Dioxide
  • Chemokine CXCL5
  • Receptors, Interleukin-8B